HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Augmentation of paroxetine with clocapramine in panic disorder.

AuthorsMasanori Saito, Hitoshi Miyaoka
JournalPsychiatry and clinical neurosciences (Psychiatry Clin Neurosci) Vol. 61 Issue 4 Pg. 449 (Aug 2007) ISSN: 1323-1316 [Print] Australia
PMID17610675 (Publication Type: Letter)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
  • Central Nervous System Stimulants
  • Dibenzazepines
  • Paroxetine
  • 3-chlorocarpipramine
Topics
  • Adult
  • Akathisia, Drug-Induced (psychology)
  • Antidepressive Agents, Second-Generation (adverse effects, therapeutic use)
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Central Nervous System Stimulants (adverse effects, therapeutic use)
  • Dibenzazepines (adverse effects, therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Panic Disorder (drug therapy, psychology)
  • Paroxetine (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: